“a favorable trend”

Our survival analysis revealed a consistency in short-term (in-hospital) mortality across both periods, while demonstrating a favorable trend toward lower one-year mortality in recent years, with multivariable Cox regression confirming that admission during the late period was independently associated with improved survival.

The ratios HDLc to non-HDLc and HDLc to TC showed a favorable trend during the intervention period.

Furthermore, by analyzing the influence of intellectual functioning, results demonstrated a favorable trend of reduction of severity of illness and amelioration of global functioning associated with higher IQ.

See Figure 5 , which shows a favorable trend in final astigmatism is observed when intraoperative aberrometry guides correction in patients where the vector difference between adjusted preoperative and intraoperative cylinder is <0.5 D.

Given the 8‐week duration of the intervention, these findings should be regarded as preliminary evidence of a favorable trend rather than a definitive clinical reversal of metabolic dysfunction.

Although statistical significance was not achieved, CREF demonstrated a favorable trend in outcomes.

8.5 months, suggesting a favorable trend. 286 These results indicate that stroma-directed therapies may require biomarker-based patient selection, and that patients with high hyaluronan levels are more likely to experience clinical benefit from improved drug delivery.

The 55% and 60% groups showed a favorable trend in smaller prescription isodose volume spillage; however, no significance was observed in other evaluation metrics.

By taking a deeper look at the dose-response for muscle tissue development, particular attention has been given to the elbow flexor and knee extensor muscles, with the available literature, sustaining a favorable trend toward the impact of RT on these muscle complexes [ 92 , 95 , 96 ].

However, we were unable to show any significant benefit for clinical course associated with achieving deep MR, as defined by remission signature genes, although those treated with TCZ in deep MR had a favorable trend.

According to comparative trials, TCG has been shown to provide higher and more steady degrees of platelet aggregation inhibition and a favorable trend in lowering the risk of myocardial infarction compared to clopidogrel without elevating the risk of severe bleeding.

These results suggest a favorable trend in CV outcomes consistent with studies of injectable semaglutides.

Patients in the TMIT 3 group had a favorable trend compared to those in TMITs 1 and 2.

While OS data remain immature, a favorable trend was observed in the surgery group (HR 0.67).

[ 26 ] demonstrated a statistically significant reduction in pain and opioid consumption in at least one RCT, with a favorable trend observed in two others.

Owing to an insufficient sample size, although chemotherapy could not be observed as an independent prognostic factor for patients with HR−HER2− subtype small-tumor with lymph node metastasis; chemotherapy showed a favorable trend for this population.

24 In this study, the IC 50 response showed a favorable trend with a coating conjugate concentration of 2.5 μg/mL compared to the highest concentration at 5.0 μg/mL and the lowest concentration at 0.625 μg/mL.

A favorable trend was also observed in endurance, especially among girls.

We also observed a favorable trend suggesting a lower risk of cardiovascular mortality with higher levels of physical activity, lower smoking rates, and appropriate sleep duration (HR < 1).

Additionally, there was a favorable trend toward extended OS in the CB group ( Figure 1D ).

Recently, one study found that the presence of NAFLD showed a favorable trend on survival rates in CRC patients, although the data did not reach statistical significance ( P = 0.079), perhaps in part due to the small number of patients (227 patients) and poor statistical power. 20 Therefore, we aimed to design a large and more statistically robust cohort study to investigate the impact of NAFLD on the prognosis of patients with CRC.

[ 18 ] wrote: The repeated failures of even large sepsis trials to demonstrate more than a favorable trend in survival benefit with anti-TNF-α therapy raises the possibility that expectations for this therapeutic approach may have been exaggerated.

This suggests a favorable trend of an improvement in glycemia. 4 Discussion The primary objectives of this trial, to confirm tolerability, safety, and feasibility, have been met.

A significant improvement in health-related quality of life was found at three months in favor of the IG, accompanied by a favorable trend toward enhanced mood.

No major differences could be observed between growth on the different kinds of coating or with or without treatment with IGF-1/IGFBP-2, with the exception of later time points when growth on poly-L-lysin showed a favorable trend compared with growth on vitronectin and compared to treatment with IGF-1/IGFBP-2.